Financhill
Sell
42

RYTM Quote, Financials, Valuation and Earnings

Last price:
$57.32
Seasonality move :
54.9%
Day range:
$55.31 - $58.45
52-week range:
$35.17 - $68.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
25.61x
P/B ratio:
190.69x
Volume:
667.4K
Avg. volume:
899.1K
1-year change:
41.85%
Market cap:
$3.6B
Revenue:
$130.1M
EPS (TTM):
-$2.81

Earnings Data

Next earnings date for RYTM
Aug 06
2025
Most recent earnings per share
-$0.81
Missed by $0.13
(May 7/2025)
Consensus Estimate
-$0.68
(May 7/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RYTM Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/06/2025 Q2 $43.7M -- -- -$0.62 --
05/07/2025 Q1 $40.2M $32.7M -$0.81 -$0.68 -$0.13
02/26/2025 Q4 $38.5M $41.8M -$0.72 -$0.73 $0.01
11/05/2024 Q3 $32.5M $33.3M -$0.73 -$0.87 $0.14
08/06/2024 Q2 $28.8M $29.1M -$0.55 -$0.72 $0.17
05/07/2024 Q1 $26.9M $26M -$2.35 -$2.39 $0.04
02/22/2024 Q4 $25.4M $24.2M -$0.70 -$0.71 $0.01
11/07/2023 Q3 -- -- -$0.76 -$0.76 -$0.00
08/01/2023 Q2 -- -- -$0.82 -$0.78 -$0.04
05/02/2023 Q1 -- -- -$0.92 -$0.77 -$0.15
03/01/2023 Q4 -- -- -$0.75 -$0.78 $0.03
11/08/2022 Q3 -- -- -$0.79 -$0.98 $0.19
08/02/2022 Q2 -- -- -$0.89 -$1.03 $0.14
05/03/2022 Q1 -- -- -$1.05 -$1.04 -$0.01
03/01/2022 Q4 -- -- -$0.85 -$0.93 $0.08
11/02/2021 Q3 -- -- -$0.70 -$0.83 $0.13
08/03/2021 Q2 -- -- -$0.70 -$0.74 $0.04
05/03/2021 Q1 -- -- $0.90 -$0.70 $1.60
03/01/2021 Q4 -- -- -$0.79 -$0.79 --
11/02/2020 Q3 -- -- -$0.77 -$0.80 $0.03
08/03/2020 Q2 -- -- -$0.71 -$0.82 $0.11
05/04/2020 Q1 -- -- -$0.78 -$0.82 $0.04
03/02/2020 Q4 -- -- -$0.78 -$0.92 $0.14
11/01/2019 Q3 -- -- -$1.04 -$1.10 $0.06
07/29/2019 Q2 -- -- -$1.24 -$0.85 -$0.39
05/03/2019 Q1 -- -- -$0.84 -$0.73 -$0.11
03/08/2019 Q4 -- -- -$0.74 -$0.66 -$0.08
11/09/2018 Q3 -- -- -$0.52 -$0.61 $0.09
08/08/2018 Q2 -- -- -$0.52 -$0.47 -$0.05
05/14/2018 Q1 -- -- -$0.60 -- --
03/12/2018 Q4 -- -- -$0.41 -$0.55 $0.14
11/14/2017 Q3 -- -- -$0.66 -$0.56 -$0.11

Rhythm Pharmaceuticals Earnings Questions

  • How Much did Rhythm Pharmaceuticals Generate in Revenue Last Quarter?

    Rhythm Pharmaceuticals reported $32.7M worth of top line sales in its most recent quarter.

  • Did Rhythm Pharmaceuticals Beat Earnings Last Quarter?

    Rhythm Pharmaceuticals announced earnings per share of -$0.81 which represents a miss of analyst forecast a -$0.68 per share.

  • Is Rhythm Pharmaceuticals Profitable?

    Rhythm Pharmaceuticals reported $29.1M that represents $0.46 per share over the last quarter.

  • What is the Analyst Consensus for Rhythm Pharmaceuticals EPS Next Year?

    Rhythm Pharmaceuticals's earnings are forecast to decrease from -$4.34 per share to -$4.07 per share next year representing a decrease of -39.34%.

  • When is Rhythm Pharmaceuticals's Earnings Date?

    Rhythm Pharmaceuticals's next earnings date is August 6, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Is Acuity a Good Stock to Buy Now?
Is Acuity a Good Stock to Buy Now?

Acuity Brands (NYSE:AYI) is an industrial company specializing in lighting.…

What Stocks Are Recession-Proof?
What Stocks Are Recession-Proof?

Fears of a recession prevailed in Q2 2025 when the…

Stock Ideas

Buy
68
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
74
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 44x

Alerts

Buy
55
RGC alert for May 15

Regencell Bioscience Holdings [RGC] is up 8.9% over the past day.

Buy
71
NUTX alert for May 15

Nutex Health [NUTX] is up 26.31% over the past day.

Buy
81
EXEL alert for May 15

Exelixis [EXEL] is up 20.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock